GILD News 74.08 04/25/2014 05:35:05 Gilead Sciences (GILD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 74.08 $GILD

What You Should Know About Gilead's Sovaldi And Johnson & Johnson's Olysio
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 24, 5:30PM CDT
Over the past five years, few drugs have been as highly anticipated as Gilead's Sovaldi, a new-generation oral treatment for hepatitis C infection. Sovaldi won FDA approval in December, and despite only being available for a few weeks, Sovaldi...

Final Glance: Biotechnology companies
AP - Thu Apr 24, 5:04PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

Alexion Posts Strong Earnings in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 4:00PM CDT
Alexion (ALXN) handsomely beat the Zacks Consensus Estimate in the first quarter.

Celgene Beats on First-Quarter Earnings: What's Next?
George Budwell, The Motley Fool - Motley Fool - Thu Apr 24, 1:30PM CDT
Source: www.fiercepharma.com. Celgene Corporation    is the second-largest component of the  iShares Nasdaq Biotech Index  . As such, its 14% plus nosedive year to date has undoubtedly played a role in driving this key biotech index lower for...

Midday Glance: Biotechnology companies
AP - Thu Apr 24, 12:28PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:

Early Glance: Biotechnology companies
AP - Thu Apr 24, 9:32AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:

Stock Market News for April 24, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 9:06AM CDT
Benchmarks ended lower on Wednesday following disappointing corporate results and economic data

Ambit Biosciences Slumps: AMBI Falls 7.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 7:49AM CDT
Ambit Biosciences saw a big move last session, as the company’s shares fell by over 7% on the day

Why Gilead Sciences (GILD) Isn't Done Growing Earnings Yet - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 7:47AM CDT
Gilead Sciences is well-positioned for future earnings growth

Earnings from Gilead and Amgen Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 7:00AM CDT
Solid results from Gilead, but poor results from Amgen, look to have a big impact on these health care ETFs.

Strategists Dismiss Nasdaq, Nikkei Wobbles
at The Street - Thu Apr 24, 5:00AM CDT
Wobbles in the Nasdaq this year are not a 'canary in the coalmine' for a broader pullback in markets, strategists say, pointing to the concentrated nature of weakness in tech and biotech stocks.

Should You Invest in Gilead Sciences, Inc. Today?
Mark Reeth, The Motley Fool - Motley Fool - Wed Apr 23, 5:30PM CDT
Shares of biopharma giant Gilead Sciences    were up today after it announced a strong quarter, which included revenue doubling to $5 billion and earnings per share tripling from $0.43 to $1.33. Most of the company's strength this quarter came...

Most active Nasdaq-traded stocks
AP - Wed Apr 23, 5:04PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

AbbVie Files for HCV Combination Therapy in U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 4:21PM CDT
AbbVie submitted a NDA to the FDA for its investigational hepatitis C virus infection therapy.

Stocks Slip on Deep Drop in U.S. Home Sales
at The Street - Wed Apr 23, 3:24PM CDT
Major U.S. stock markets slide Wednesday amid poor Chinese economic data and a 14.5% month-over-month drop in U.S. new-home sales.

Earnings Roundup: What You Need to Know About Gilead's Blockbuster Quarter
Todd Campbell, The Motley Fool - Motley Fool - Wed Apr 23, 1:30PM CDT
Gilead's investors were wondering how long it would take for the company's newly launched hepatitis C drug Sovaldi to become a blockbuster; investors found out this week that the answer was less than one quarter. Sovaldi's sales totaled $2.3...

Stocks Trading Lower In Afternoon Action
at Investor's Business Daily - Wed Apr 23, 12:40PM CDT
Stocks were trading lower in early afternoon action Wednesday as the season for earnings reports hit full stride. The Nasdaq was down 0.6%, while the S&P 500 and the Dow Jones industrial average were off less than 0.1% each. Volume was running lower...

Biogen's Q1 Earnings Soar Y/Y on Tecfidera Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 12:40PM CDT
Although Biogen (BIIB) missed earnings estimates, revenues surpassed expectations easily. The company also raised its guidance.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Concierto's Azure Push Puts Sovereignty on Display

Updated Category News Views 78

Sovereignty has become the corporate cloud world's favorite hard-edged word. Concierto is taking that word straight onto the Microsoft Ignite 2026 floor, and frankly, it is a sensible place to make the case. The company, part of Trianz, will appear as a Gamechanger Sponsor from November 17 through 20 at San Francisco's Moscone Center, showing its platform at Booth #5435....

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 104

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 105

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 55

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 66

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 340

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
ZTO's Pricing Muscle Shows Up in Third-Quarter Results

Updated Category News Views 87

Ten billion parcels can hide plenty of ugly economics, but ZTO's third quarter does not look like a volume-at-any-cost stunt. The company moved 10.241 billion parcels, up 7.0% from a year earlier, and says that outpaced the industry by 4.1 percentage points. More importantly, revenue climbed 21.0% to RMB14.36 billion while adjusted net income reached RMB2.57 billion. That...

Continue Reading
Kobo and CloudLibrary Make Library Ebooks Much Easier

Updated Category News Views 107

A tiny button can change whether a digital service gets used Borrowing an ebook ought not feel like assembling a radio in a dark garage, yet that is roughly where library reading has landed for plenty of people. OCLC's new CloudLibrary integration with Kobo strips out a particularly annoying step: U.S. and Canadian users can link accounts once, borrow a title, and have it...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 59

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor

Updated Category News Views 197

Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...

Continue Reading

Top 5 Most Recently Viewed Articles

Ringkjøbing Landbobank's Impressive Mid-Year Financial Update

Updated Category News Views 214

Ringkjøbing Landbobank's Financial Performance for 2025 In an exciting turn of events, Ringkjøbing Landbobank has shared its quarterly report for the first half of 2025, revealing remarkable financial outcomes that have caught the attention of analysts and stakeholders alike. Approval from Management The bank's board of directors, along with its general management, has...

Continue Reading
Mercy Medical Opens Center for Orthopedic Innovation

Updated Category News Views 42

Foot and Ankle Care Leap at Mercy Medical Mercy Medical Center in Baltimore is shaking things up in the orthopedic world. On August 10, 2026, they pulled the curtain back on the Center for Orthopedic Innovation, a place where the future of foot and ankle care is being molded. Led by renowned figure Dr. Lew Schon, they've crafted a cutting-edge space that’s all about...

Continue Reading
GECU's $4.9B Milestone: Navigating Regulatory Hurdles

Updated Category News Views 49

GECU's Bold Step: Merging with Bank of the Southwest When the gears of the financial world start grinding, there's no room for hesitation. GECU, one of the powerhouses when it comes to credit unions locally in Texas and New Mexico, has just snagged the regulatory green light to merge with the Bank of the Southwest. Talk about making moves—this transition's poised to...

Continue Reading
Taiwan's Economic Surge Driven by AI Innovations and Exports

Updated Category News Views 264

Economic Growth Outlook in Taiwan Taiwan has recently upgraded its economic growth forecast, reflecting its robust performance amid the ongoing AI revolution. As global appetite for AI-driven technology continues to surge, Taiwan is poised to reap substantial benefits. AI-Driven Exports In a remarkable display of economic resilience, Taiwan's exports skyrocketed almost...

Continue Reading
Exceptional Gold Intersections Reported at Keats Trench

Updated Category News Views 111

Major Discoveries in Gold Exploration New Found Gold Corp. (TSXV: NFG) (NYSE-A: NFGC) is thrilled to disclose impressive results from the second phase of channel sampling at Keats Trench as part of its ongoing exploration efforts at the Queensway Project. Highlights from Keats Trench Phase II The company noted exceptional intercepts in its sampling campaign, including...

Continue Reading